Expression of phase I and phase II genes in mouse embryonic stem cells cultured in the presence of 2,3,7,8-tetrachlorodibenzo-para-dioxin

Biochimica et Biophysica Acta - General Subjects

Volumn 1780, Issue 5, 2008, Pages 826-836

  Neri, Tui ^a   Merico, Valeria ^a   Garagna, Silvia ^a   Redi, Carlo Alberto ^a,b   Zuccotti, Maurizio ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Ahr gene battery; Dioxin; Embryonic stem cell

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; GLUCURONOSYLTRANSFERASE 1A6; GLUTATHIONE TRANSFERASE A1; XENOBIOTIC AGENT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); CYP1A1 GENE; CYP1A2 GENE; CYP1B1 GENE; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENZYME SYNTHESIS; GENE; GENE EXPRESSION; GENE INDUCTION; GSTA1 GENE; MOUSE; NONHUMAN; NQO1 GENE; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UGT1A6 GENE;

ANIMALS; ANTIGENS, DIFFERENTIATION; APOPTOSIS; ARYL HYDROCARBON HYDROXYLASES; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYONIC STEM CELLS; GENE EXPRESSION; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; ISOENZYMES; KINETICS; MICE; NADPH DEHYDROGENASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRACHLORODIBENZODIOXIN; TIME FACTORS;

MAMMALIA;

EID: 45049088856     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2008.02.002     Document Type: Article

References (51)

1. Spielmann H. Predicting the risk of developmental toxicity from in vitro assays. Toxicol. Appl. Pharmacol. 207 (2005) 375-380
2. Jelinek R., and Marhan O. Validation of the chick embryotoxicity screening test (CHEST). A comparative study. Funct. Dev. Morphol. 4 (1994) 317-323
3. Bantle J.A., Fort D.J., Rayburn J.R., DeYoung D.J., and Bush S.J. Further validation of FETAX: evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens. Drug Chem. Toxicol. 13 (1990) 267-282
4. Sadler T.W., Horton W.E., and Warner C.W. Whole embryo culture: a screening technique for teratogens?. Teratog. Carcinog. Mutagen. 2 (1982) 243-253
5. Schmid B.P. Teratogenicity testing of new drugs with post-implantation embryo culture system. In: Homburger F. (Ed). Concepts in Toxicology vol. 3 (1985), Karger Publ., Basel 46-57
6. Spielmann H., Pohl I., Doring B., Liebsch M., and Moldenhauer F. The embryonic stem cell (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicol. 10 (1997) 119-127
7. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
8. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 7634-7638
9. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
10. Loebel D.A., Watson C.M., De Young R.A., and Tam P.P. Lineage choice and differentiation in mouse embryos and embryonic stem cells. Dev. Biol. 264 (2003) 1-14
11. Weitzer G. Embryonic stem cell-derived embryoid bodies: an in vitro model of eutherian pregastrulation development and early gastrulation. Handb. Exp. Pharmacol. 174 (2006) 21-51
12. Kim S.K., Kim B.K., Shim J.H., Gil J.E., Yoon Y.D., and Kim J.H. Nonylphenol and octylphenol-induced apoptosis in human embryonic stem cells is related to Fas-Fas ligand pathway. Toxicol. Sci. 94 (2006) 310-321
13. Rolletschek A., Blyszczuk P., and Wobus A.M. Embryonic stem cell-derived cardiac, neuronal and pancreatic cells as model systems to study toxicological effects. Toxicol. Lett. 149 (2004) 361-369
14. Seiler A., Visan A., Buesen R., Genschow E., and Spielmann H. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod. Toxicol. 18 (2004) 231-240
15. zur Nieden N.I., Kempka G., and Ahr H.J. Molecular multiple endpoint embryonic stem cell test - a possible approach to test for the teratogenic potential of compounds. Toxicol. Appl. Pharmacol. 194 (2004) 257-269
16. Mandal P.K. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J. Comp. Physiol. 175 (2005) 221-230
17. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., and Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59 (2000) 65-85
18. Neri T., Monti M., Rebuzzini P., Merico V., Garagna S., Redi C.A., and Zuccotti M. Mouse fibroblasts are reprogrammed to Oct-4 and Rex-1 gene expression and alkaline phosphatase activity by embryonic stem cell extracts. Cloning Stem Cells 9 (2007) 394-406
19. Choudhary D., Jansson I., Stoilov I., Sarfarazi M., and Schenkman J.B. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch. Biochem. Biophys. 436 (2005) 50-61
20. Nebert D.W., Dalton T.P., Okey A.B., and Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279 (2004) 23847-23850
21. Thackaberry E.A., Jiang Z., Johnson C.D., Ramos K.S., and Walker M.K. Toxicogenomic profile of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the murine fetal heart: modulation of cell cycle and extracellular matrix genes. Toxicol. Sci. 88 (2005) 231-241
22. Nebert D.W. The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20 (1989) 153-174
23. Nebert D.W. Comparison of gene expression in cell culture to that in the intact animal: relevance to drugs and environmental toxicants. Focus on "development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes". Am. J. Physiol., Cell Physiol. 290 (2006) C37-C41
24. Wu Q., Ohsako S., Baba T., Miyamoto K., and Tohyama C. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on preimplantation mouse embryos. Toxicology 174 (2002) 119-129
25. Dey A., Westphal H., and Nebert D.W. Cell-specific induction of mouse Cyp1a1 mRNA during development. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 7446-7450
26. Gradin K., Wilhelmsson A., Poellinger L., and Berghard A. Nonresponsiveness of normal human fibroblasts to dioxin correlates with the presence of a constitutive xenobiotic response element-binding factor. J. Biol. Chem. 268 (1993) 4061-4068
27. Poland A.P., Glover E., Robinson J.R., and Nebert D.W. Genetic expression of aryl hydrocarbon hydroxylase activity. Induction of monooxygenase activities and cytochrome P1-450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically "nonresponsive" to other aromatic hydrocarbons. J. Biol. Chem. 249 (1974) 5599-5606
28. Robinson J.R., Considine N., and Nebert D.W. Genetic expression of aryl hydrocarbon hydroxylase induction. Evidence for the involvement of other genetic loci. J. Biol. Chem. 249 (1974) 5851-5859
29. Chaloupka K., Santostefano M., Goldfarb I.S., Liu G., Myers M.J., Tsyrolv I.B., Gelboin H.V., Krishnan V., and Safe S. Aryl hydrocarbon (Ah) receptor-independent induction of Cyp1a2 gene expression by acenaphthylene and related compounds in B6C3F1 mice. Carcinogenesis 15 (1994) 2835-2840
30. Nerurkar P.V., Anderson L.M., Snyderwine E.G., Park S.S., Thorgeirsson S.S., and Rice J.M. Specific induction of hepatic cytochrome P4501a-2 in C57BL/6 and DBA/2 mice treated with 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). J. Biochem. Toxicol. 8 (1993) 175-186
31. Tijet N., Boutros P.C., Moffat I.D., Okey A.D., Tuomisto J., and Pohjanvirta P. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol. Pharmacol. 69 (2006) 140-153
32. Abbott B.D., Schmid J.E., Brown J.G., Wood C.R., White R.D., Buckalew A.R., and Held G.A. RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol. Sci. 47 (1999) 76-85
33. Bryant P.L., Clark G.C., Probst M.R., and Abbott B.D. Effects of TCDD on Ah receptor, ARNT, EGF, and TGF-alpha expression in embryonic mouse urinary tract. Teratology 55 (1997) 326-337
34. Huang P., Rannug A., Ahlbom E., Hakansson H., and Ceccatelli S. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the expression of cytochrome P450 1A1, the aryl hydrocarbon receptor, and the aryl hydrocarbon receptor nuclear translocator in rat brain and pituitary. Toxicol. Appl. Pharmacol. 169 (2000) 159-167
35. Elferink C.J. Aryl hydrocarbon receptor-mediated cell cycle control. Prog. Cell Cycle Res. 5 (2003) 261-267
36. Camacho I.A., Nagarkatti M., and Nagarkatti P.S. Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci. 78 (2004) 96-106
37. Heimler I., Rawlins R.G., Owen H., and Hutz R.J. Dioxin perturbs, in a dose- and time-dependent fashion, steroid secretion, and induces apoptosis of human luteinized granulosa cells. Endocrinology 139 (1998) 4373-4379
38. Zaher H., Fernandez-Salguero P.M., Letterio J., Sheikh M.S., Fornace Jr. A.J., Roberts A.B., and Gonzalez F.J. The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis. Mol. Pharmacol. 54 (1998) 313-321
39. Exley G.E., Tang C., McElhinny A.S., and Warner C.M. Expression of caspase and BCL-2 apoptotic family members in mouse preimplantation embryos. Biol. Reprod. 61 (1999) 231-239
40. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
41. Matikainen T., Perez G.I., Jurisicova A., Pru J.K., Schlezinger J.J., Ryu H.Y., Laine J., Sakai T., Korsmeyer S.J., Casper R.F., Sherr D.H., and Tilly J.L. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat. Genet. 28 (2001) 355-360
42. Shen E.S., and Whitlock Jr. J.P. The potential role of DNA methylation in the response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 264 (1989) 17754-17758
43. Takahashi Y., Suzuki C., and Kamataki T. Silencing of CYP1A1 expression in rabbits by DNA methylation. Biochem. Biophys. Res. Commun. 247 (1998) 383-386
44. Weissman I.L., Anderson D.J., and Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. 17 (2001) 387-403
45. Lorick K.L., Toscano D.L., and Toscano Jr. W.A. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters retinoic acid receptor function in human keratinocytes. Biochem. Biophys. Res. Commun. 243 (1998) 749-752
46. Crawford R.B., Sulentic C.E., Yoo B.S., and Kaminski N.E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells. Toxicol. Sci. 75 (2003) 333-342
47. Abbott B.D., Diliberto J.J., and Birnbaum L.S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters embryonic palatal medial epithelial cell differentiation in vitro. Toxicol. Appl. Pharmacol. 100 (1989) 119-131
48. Alexander D.L., Ganem L.G., Fernandez-Salguero P., Gonzalez F., and Jefcoate C.R. Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis. J. Cell Sci. 111 (1998) 3311-3322
49. Cavaleri F., and Scholer H. Molecular facets of pluripotency. In: Lanza R., Gearhart J., Hogan B., Melton D., Pedersen R., Thompson J., and West M. (Eds). Stem Cells (2005), Elsevier Academic Press, Amsterdam 27-44
50. Brosens J.J., and Parker M.G. Gene expression: oestrogen receptor hijacked. Nature 423 (2003) 487-488
51. Murphy C.L., and Polak J.M. Differentiating embryonic stem cells: GAPDH, but neither HPRT nor beta-tubulin is suitable as an internal standard for measuring RNA levels. Tissue Eng. 8 (2002) 551-559